In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases

In situ-based gel drug delivery systems that can bypass the blood-brain barrier, deliver the therapeutics to the desired site, reduce peripheral toxicity and control drug release kinetics have been developed. Some of the therapeutics used to treat neurological diseases suffer from poor bioavailabili...

Descripción completa

Detalles Bibliográficos
Autor principal: Aderibigbe, Blessing Atim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027251/
https://www.ncbi.nlm.nih.gov/pubmed/29601486
http://dx.doi.org/10.3390/pharmaceutics10020040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027251/
https://www.ncbi.nlm.nih.gov/pubmed/29601486
http://dx.doi.org/10.3390/pharmaceutics10020040

Ejemplares similares